Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Aquestive Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Pharmaceutical Preparations
No intraday reading yet this session.
186 institutional managers report a position in Aquestive Therapeutics, Inc. worth $306.5M between them, filed on form 13F for the quarter ending 2026-06-30. 24 of them hold 80% of it, the largest being Bratton Capital Management, L.P. at 13.32%.
161 more managers in the register
24 managers hold 80% of the $306.5M institutional base. The other 162 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via RTW Investments, LLC, Propel Bio Management, LLC, Balyasny Asset Management LLC +2 more · 10.08% of AQST, 15.72% of MIST
via RTW Investments, LLC, Propel Bio Management, LLC, DAFNA Capital Management LLC +1 more · 10.08% of AQST, 34.51% of OBIO
via RTW Investments, LLC, DAFNA Capital Management LLC, Propel Bio Management, LLC +3 more · 10.08% of AQST, 11.07% of CMPS
via RTW Investments, LLC, Federated Investors Inc, Marshall Wace LLP · 10.08% of AQST, 17.68% of RCKT
via RTW Investments, LLC, Samsara BioCapital, LLC, Balyasny Asset Management LLC +1 more · 10.08% of AQST, 7.81% of NGNE
via RTW Investments, LLC, Wasatch Advisors Inc, HRT Financial LLC +1 more · 10.08% of AQST, 10.13% of CSTL
Managers holding a meaningful stake in AQST also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
AQST (Aquestive Therapeutics, Inc.) has 0 disclosed suppliers and 14 disclosed customers, strongest disclosure first.
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move, and a bundle sits past the rings until you open it. Extended: satellites hang off single companies, not bundled sectors.